It may mean her uncle Alec Baldwin losing his "Saturday Night Live" gig — the actor famously spoofs President Trump on the comedy show — but Hailey Bieber (née Baldwin) is officially endorsing Joe Biden for president.
It may mean her uncle Alec Baldwin losing his "Saturday Night Live" gig — the actor famously spoofs President Trump on the comedy show — but Hailey Bieber (née Baldwin) is officially endorsing Joe Biden for president.
Yahoo Finance presents the All Markets Summit: Road to Recovery, a fully virtual event anchored from the Nasdaq in New York’s Times Square.
The "Global Anti-Money Laundering Software Market: Focus on Software Type, Deployment Mode, and End User - Analysis and Forecast, 2020-2025" report has been added to ResearchAndMarkets.com's offering.
(Bloomberg) -- The last time Zambia renegotiated its external debt, the well-oiled machine established by institutional lenders and western governments handled it with little trouble.But 15 years later, with the southern African nation in the throes of a $12 billion debt overhaul, China and bondholders have emerged as powerful new players to upend the choreography.Beijing is embroiled in a feud with money managers in New York and London, putting the impoverished nation in the middle. The outcome of the dispute over the billions Zambia borrowed from both sides could define how developing countries address debt crises from now on.“The precedent set in Zambia is likely to be the one that everyone points to in the next couple of years as we have multiple sovereign debt workouts,” said Lee Buchheit, one of the world’s most prominent debt-restructuring lawyers. “This is the beginning of a new era.”Mutual SuspicionEthiopia, Kenya and the Republic of Congo are among fiscally challenged African nations with high levels of Chinese debt. But with the coronavirus pandemic punishing economies around the world, the problem is wider than just Africa: the Maldives, Kyrgyz Republic and Venezuela are among the largest recipients of largesse from the world’s newest financial powerhouse, according to a study co-authored by the World Bank’s chief economist, Carmen Reinhart.At the heart of the battle in Zambia is the suspicion from both sides that any relief granted to one would be used to repay the other. The players don’t trust each other and are barely on speaking terms. Bondholders delayed a key vote on Tuesday to defer coupon payments, with the next meeting set for Nov. 13.In previous debt crises of the 1980s and 1990s, rich western governments grouped in the so-called Paris Club and commercial banks mostly from the same countries worked together to write off loans in exchange for budget cuts and promises to curb corruption. That world has changed dramatically.China has become the world’s largest non-commercial lender, surpassing the International Monetary Fund and World Bank. In the past two decades, financing roads, airports and hospitals across Africa, Asia and Latin America has driven China’s loans and trade credits to the rest of the world to $1.6 trillion, or close to 2% of global gross domestic product, in 2018, from near-zero in 1998, according to the Reinhart study.In just eight years since 2010, China extended $121 billion in loans to African nations. In addition, bondholders interested in the relatively high returns have provided $83 billion of risky debt in the same period, according to data compiled by Bloomberg.“As a rising power, China has very different objectives in Africa than the private bondholders,” said Martyn Davies, Deloitte’s managing director for emerging markets and Africa. “I just can’t see how these interests can reconcile.”Not only are their objectives different, but communication between them is almost nonexistent.‘Tried Hard’“We and other bondholders have tried very hard to engage with China,” said Lars Bane, a partner at London-based Farallon Capital Europe LLP and member of a group of private creditors holding regular talks with African borrowers. “It would certainly be beneficial for everyone to have better lines of communication so that we can all collaborate to work toward solutions, rather than the current silence.”China has called on bondholders to follow its lead in granting relief to poor countries. Its official credit agency, the Export-Import Bank of China, has signed deals with 11 African countries to ease payment terms, Chinese foreign ministry spokesman Zhao Lijian said on Oct. 12. China would support equal treatment of all creditors, Wu Peng, head of the Africa department at the foreign ministry, said in a tweet on Oct. 20.As a member of the Group of 20 leading economies, China earlier this month backed the renewal of a debt-relief initiative for the poorest countries through at least the first half of 2021. After some initial opposition, China also agreed to coordinate debt negotiations with the Paris Club, a move which could increase transparency.But increasing tensions between the U.S. and China could undermine any rapprochement between Beijing and bondholders, said Ye Yu, an associate research fellow at the Shanghai Institutes for International Studies.“High-level dialogue between the two could have provided a channel for China to communicate with private investors,” Ye said. “China feels that it’s contributing the most to the debt-relief initiative, but it’s still getting blamed for the debt problems abroad.”Chinese lenders have so far been more lenient with African borrowers than private creditors. Over the past decade, China has restructured and refinanced about $15 billion of debt in Africa without slapping penalties or seizing assets from borrowers, according to a Johns Hopkins University study.“China has been used a lender of last resort by countries like Zambia,” said Irmgard Erasmus, a Paarl, South Africa-based economist at NKC African Economics. “It’s a delicate game of theory for borrowers because China is a creditor that could help out after the crisis even if you have a bad credit record.”Angering bondholders could lock governments out of debt markets for years, while irritating China would risk losing a reliable financier, making the IMF a potential mediator.The renegotiation strategy may depend on the nature of a country’s exposure. Earlier this year Ecuador, which owes most of its debt to bondholders, first clinched a deal to reschedule payments to private creditors before agreeing to delay payments to Chinese banks. With the vast majority of its debt owed to China, Angola reached an agreement with Chinese lenders while it vowed to keep paying interest to bondholders.In both cases, the IMF played a role with fresh credit, raising hopes that the global lender could serve as mediator to bring China and bondholders to the table. The lender also named a new representative to Zambia, two years after the post was vacated.It could exert pressure on debtor countries by making funding contingent on restructuring, but its influence on creditors is limited.“The agendas are not necessarily aligned, and IMF does not have the legitimacy necessary to be the arbiter,” said Agatha Kratz, associate director at Rhodium Group. “At the end of the day, Chinese banks and private creditors don’t want to be told what to do.”(Updates with new IMF representative in Zambia in third-last paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Most readers would already be aware that Hub Group's (NASDAQ:HUBG) stock increased significantly by 6.4% over the past...
A new report claims the actor popped the question after three months
Upon nearing the swamp, Hercules was forced to cover his mouth and nose with a cloth in order to protect himself from the poison that wafted through the air. Hercules used something else too, though. Upon instinct, Hercules would decapitate one head, then another.
Ford Taurus station wagon production ended in 2004, and the Detroit Wagon Era died with it.
The German business software company revised down its 2020 outlook and pushed its 2023 “ambition” two years out. Shares plunged in Europe.
(Bloomberg) -- SAP SE shares dropped as much as 21%, the biggest intraday fall since 1999, after the software company cut its revenue forecast for the full year and said it expects a fresh wave of lockdowns to hurt demand through the first half of 2021.In a test for Christian Klein, who became sole chief executive officer in April, the pandemic will delay SAP’s goals for cloud revenue, overall sales and operating profit by one or two years, especially in hard-hit industries such as business travel, the Walldorf, Germany-based company said in a statement on Sunday. The drop in shares on Monday wiped 28 billion euros ($33.1 billion) off SAP’s market value.The drop-off in SAP’s cloud revenue is a sign that companies are putting off making major decisions about updating their software, as the pandemic continues to limit any global economic recovery.SAP said it expects limited growth and margin improvement over the next two years, and moved expectations to meet its 2023 strategy plan out to 2025. Klein said on a call Monday he expects a conservative recovery into the first half of next year.The previous outlook “assumed economies would reopen and population lockdowns would ease, leading to a gradually improving demand environment in the third and fourth quarters,” SAP said in the statement. “Lockdowns have been recently re-introduced in some regions and demand recovery has been more muted than expected.”The pessimistic short-term outlook from SAP risked a knock-on effect on the European software industry, warned analysts at Citi. Europe’s Stoxx Technology index fell as much as 6.3%, its biggest one-day loss since March.SAP now expects adjusted revenue of 27.2 billion euros to 27.8 billion euros ($32.2 billion to $32.9 billion) at constant currencies in 2020, lower than the earlier guidance of 27.8 billion euros to 28.5 billion euros. SAP also said it no longer sees a boost from business-travel related revenue this year in its Concur business.It’s difficult to find positive news in the results, Nicholas David, an analyst at Oddo BHF said Monday. “The warning on the mid-term ambitions was expected/feared by the market but the new ambitions are lower than the most pessimistic expectations,” he said in a note.Qualtrics IPOSAP said it is in the advanced stages of a listing for its Qualtrics software unit. It announced the decision in July to list the U.S. unit less than two years after buying the company for a record sum, a surprise u-turn signaling a strategic shift under Klein.“We are well advanced in the preparations of the Qualtrics IPO”, Chief Financial Officer Luka Mucic said on a call Monday. “Qualtrics has had a strong quarter which will set it up for further growth into next year.”New OutlookAdjusted cloud revenue is expected to be 8 billion euros to 8.2 billion euros in 2020, down from a previous estimate of 8.3 billion euros to 8.7 billion euros.Operating profit will be 8.1 billion euros to 8.5 billion euros this year, down from expectations of as much as 8.7 billion euros.SAP updated its mid-term ambition for total revenue to more than 36 billion euros in 2025 compared to its previous estimate of 35 billion euros in 2023.The company sees more than 22 billion euros in cloud revenue and over 11.5 billion euros in operating profit by 2025.Third QuarterThird quarter non-IFRS operating profit decreased by 12% year over year to 2.07 billion euros. That compared to the 2.15 billion-euro average estimate from analysts in a Bloomberg survey.Revenue in the period declined 4% to 6.54 billion euros compared to analysts’ average 6.89 billion euro estimate.Get MoreRead the full statement here.After Losing Co-Pilot, SAP CEO Plots Solo Path Through PandemicU.K.’s CMA to Start Antitrust Probe on Sinch, SAP Unit DealSAP Is Said to Tap Morgan Stanley, JPMorgan for Qualtrics IPO(Updates with context from paragraph three.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Porsche driver Nick Tandy has revealed that he cried with emotion as he completed victory in last weekend's Spa 24 Hours with the Rowe Racing team
North America is projected to lead the global armor materials market owing to advancement in the technology and presence of key industrial playersDallas, Texas, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The “Armor Materials Market by Material Type (Metals & Alloys, Ceramics & Composites, Para-Aramid Fiber, Ultra-High-Molecular-Weight Polyethylene, Fiberglass, Others), by Application (Vehicle Armor, Aerospace Armor, Body Armor, Civil Armor, Marine Armor) and by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) and Global Forecasts 2018 to 2028” study provides an elaborative view of historic, present and forecasted market estimates.Request a pdf sample at https://www.adroitmarketresearch.com/contacts/request-sample/1669Strength to weight ratio of armor materials plays vital role in the manufacturing of end products. With several stages of development in the armor material since inception the market is further projected to witness huge opportunity over the forecast period. The market is projected to reach more than USD 16 billion by the end of 2028.In terms of material type, the global armor material market is segmented into metals & alloys, ceramics & composites, para-aramid fiber, ultra-high-molecular-weight polyethylene, fiberglass and others. Metals & alloys holds the lion share followed by ceramics and composites.Browse the full report with Table of Contents and List of Figures at https://www.adroitmarketresearch.com/industry-reports/armor-materials-marketIn terms of application, the global armor material market is segmented into vehicle armor, aerospace armor, body armor, civil armor, and marine armor. Body armor consists of various sections. In the lowest point, a jacket may have two panels that are worn over the front and back of the jacket itself. Such panels are what shield the wearer, the jacket is literally, a regular jacket without them added. Geography wise, the global armor materials market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The global application of armor material varies from region to region owing to demand, supply, presence of manufacturers, and application. North America dominated this market owing to early adoption of technology and strong military needs. However, with the passing time the market is projected to reach the stage of maturity providing other regions with growth opportunity. Asia Pacific is projected to witness strongest growth owing to presence of key developing economies such as India and China.Direct purchase the report at https://www.adroitmarketresearch.com/researchreport/purchase/1669Key players include DuPont, DSM NV, Honeywell International Inc., Compagnie de Saint-Gobain SA, Allegheny Technologies Incorporated, Ceradyne, Inc., Alcoa Corporation, Royal TenCate NV, Saab AB, CoorsTek Inc., Morgan Advanced Materials, CeramTec GmbH, Tata Steel Limited, AGY Holding Corp., PPG Industries Inc.Are you looking for a DISCOUNT? If yes, then get in touch with us at https://www.adroitmarketresearch.com/contacts/discount/1669Major Points from Table of Contents: Chapter 1. Introduction Chapter 2. Research Methodology Chapter 3. Executive Summary Chapter 4. Market Outlook Chapter 5. Armor Materials Market by Material Type Chapter 6. Armor Materials Market by Application Chapter 7. Armor Materials Market by Region Chapter 8. Competitive Landscape Chapter 9. Company Profiles Chapter 10. AppendixAccess research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html About Us: Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.Contact Us: Ryan Johnson Account Manager - Global 3131 McKinney Ave Ste 600 Dallas, TX 75204 Email ID: firstname.lastname@example.org Phone No.: +1 972-362 -8199 Connect with us: Facebook | Twitter | LinkedIn
Key Prominent Players Covered in the Preeclampsia Diagnostics Market Research Report Are Thermo Fisher Scientific Inc., Diabetomics, Inc., Metabolomic Diagnostics Ltd., Sera Prognostics, Siemens Healthineers AG, Bayer AG and other key market playersPune, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The global preeclampsia diagnostics market size is anticipated to gain momentum from the increasing number of pregnancies owing to the complete lockdown amid the COVID-19 pandemic. The report further states that this market size was USD 1.06 billion in 2019 and is projected to reach USD 2.52 billion by 2027, thereby exhibiting a CAGR of 11.0% during the forecast period.Key Players Aim to Introduce Wide Product Offerings to Intensify Competition The market for preeclampsia diagnostics consists of several prominent companies that are persistently trying to gain a competitive edge by introducing a wide range of product offerings. Some of them are also trying to broaden their geographical footprint by expanding their brand presence. Below are two of the latest industry developments: * February 2019: Diabetomics introduced a rapid point-of-care test called Lumella in Hyderabad. It is a novel preeclampsia diagnosis test. * March 2019: The Ohio State University Wexner Medical Center introduced its latest urine test for preeclampsia diagnosis at an early stage. Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/preeclampsia-diagnostics-market-101519 Increasing Prevalence of Preeclampsia in Developing Nations to Boost GrowthThe increasing perinatal and maternal morbidity & mortality rate is set to surge the need for the early diagnosis of preeclampsia worldwide among pregnant women. The British Charity Action on Pre-eclampsia (APEC) declared that in the U.K. every year, around 7 mothers die on account of complications related to preeclampsia and approximately 1000 babies die owing to the same cause. The condition is majorly affecting the health of both neonates and mother, especially in the emerging countries. As per the BMC Journal, in Africa, preeclampsia affects around 10% of pregnant women annually. These factors are set to propel the preeclampsia testing market growth in the coming years. The outbreak of the COVID-19 pandemic has caused an unprecedented demand in the healthcare industry. Presently, because of the unavailability of efficient healthcare facilities and midwives, the cases of cancelled or delayed abortions have surged rapidly. Besides, the number of coronavirus positive cases amongst pregnant women is increasing, which, in turn, is resulting in the high demand for preeclampsia diagnostics. We are providing elaborate research reports to help you better understand the effects of this pandemic on every pandemic. To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/preeclampsia-diagnostics-market-101519 Instruments Segment to Grow Rapidly Owing to Their Highly Sensitive Nature Based on product type, the market is bifurcated into consumables and instruments. Out of these, the instruments segment is expected to grow significantly throughout the forthcoming period because of their highly sensitive nature. They are extensively used for fast and accurate testing for preeclampsia. High Pregnancy Rate to Drive Growth in Asia Pacific In 2019, North America generated USD 401.9 million in terms of preeclampsia screening market revenue. This growth is attributable to the significant healthcare expenditure and the rising usage of technologically advanced preeclampsia diagnostics kits in this region. Coupled with this, the increasing awareness programs amongst the patients and doctors regarding the severity of the disease would propel growth in this region. Asia Pacific, on the other hand, is expected to remain in the second position after North America backed by the increasing adoption of fertility treatments, high rate of pregnancy, and the rising population. Quick Buy - Preeclampsia Diagnostics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101519 Fortune Business Insights™ lists out the names of all the renowned preeclampsia diagnostics providers operating in the global Preeclampsia Diagnostics Market. They are as follows: * F. Hoffmann-La Roche Ltd (Basel, Switzerland) * PerkinElmer Inc. (Massachusetts, United States) * DRG INSTRUMENTS GMBH (HE, Germany) * Thermo Fisher Scientific Inc. (Massachusetts, United States) * Diabetomics, Inc. (Massachusetts, United States) * Metabolomic Diagnostics Ltd. (Munster, Ireland) * Sera Prognostics (UT, United States) * Siemens Healthineers AG (Erlangen, Germany) * Bayer AG (Leverkusen, Germany) * Others Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/preeclampsia-diagnostics-market-101519 Preeclampsia Diagnostics Market Segmentations:By Test Type• Blood Tests• Urine AnalysisBy Product Type• Instruments• ConsumablesBy End-user• Hospitals • Specialty Clinics• Diagnostic Centers• OthersBy Region• North America (the U.S. and Canada)• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)• Latin America (Brazil, Mexico, and the Rest of Latin America)• Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa) Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/preeclampsia-diagnostics-market-101519 SECONDARY DATA SOURCES THAT WE REFER TO: * Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market * Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc. * Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics * Industry journals and paid databasesSECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION: * Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies * Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc. * Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility * Number of procedures and average price of procedures * Replacement rate and pricing of capital equipment * Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities * Market & technological trends, new product developments, product pipeline. Have a Look at Related Reports: Immunodiagnostics Market Share and Global Trend By Product Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases), By End user (Clinical Laboratories, Hospitals, Physician’s Offices), By End-user(Hospitals, Dental Clinics, Academic & Research Institutes) and Geography Forecast till 2026Point of Care (POC) Diagnostics Market Share and Global Trend By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy and Fertility Testing Products, Hematology Testing Products, Others), By End User (Hospitals Bedside, Physician’s Office Lab, Urgent Care & Retail Clinics, Home and Self Testing) and Geography Forecast till 2026Molecular Diagnostics Market Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025In-vitro Diagnostics (IVD) Market Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019 – 2026 About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact Us:Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: email@example.com Fortune Business Insights™ LinkedIn | Twitter | Blogs Press Release: https://www.fortunebusinessinsights.com/press-release/preeclampsia-diagnostics-market-9457
Those following along with Del Taco Restaurants, Inc. (NASDAQ:TACO) will no doubt be intrigued by the recent purchase...
The "Global Construction Outlook to 2024 (Q3 2020 Update)" report has been added to ResearchAndMarkets.com's offering.
Dublin, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The "Theranostics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for theranostics should grow from $80.4 billion in 2020 to $129.8 billion by 2025, at a compound annual growth rate (CAGR) of 10.1% for the period of 2020-2025.The oncology segment market for theranostics should grow from $73.1 billion in 2020 to $119.7 billion by 2025, at a CAGR of 10.4% for the period of 2020-2025. The RIIDs segment market for theranostics should grow from $2 billion in 2020 to $2.8 billion by 2025, at a CAGR of 7.1% for the period of 2020-2025. During the past 20 years, the market for theranostics has been growing steadily driven in particular by companion diagnostic therapies resulting in a market that is currently valued at more than $80 billion. The main goal of this report is to provide an updated review of the most important advances in theranostic technology, with a focus on those products, applications, and strategies that will be instrumental to market growth during the next five years. In addition, a current and detailed assessment of the market for theranostics is offered, including an objective analysis of industry and technological trends, and prospects for future growth. Specifically, the major objectives of this study are to: * Provide a detailed review of theranostics, focusing on types of products, properties, materials, imaging technologies and applications. * Highlight new technological developments related to theranostics, while outlining current technical issues. * Review existing fields of application for theranostics and examine emerging applications. * Estimate current global markets for theranostics by category, product type, application, and region, with growth forecasts through 2025 for each market segment. * Identify important technology and industry trends within each market segment. * Offer an updated review of current industry players, including manufacturers of products used in theranostics, reagents, and instrumentation for theranostics research, as well as suppliers of theranostic-related services, technology developers, and future market participants. * Provide a description of the most relevant research and development activities. * Determine trends in recently issued U.S. patents.Scope of the ReportThis report provides an updated review of theranostics, including materials, equipment, and strategies, and identifies current and emerging applications for theranostic products. The publisher delineates the current market status for theranostics, defines trends, and presents growth forecasts for the next five years. The theranostics market is analyzed based on the following segments: category, product type, application, and region. In addition, technological issues, including key events and the latest developments, are discussed. The report includes: * An updated overview of the global markets for theranostics with emphasis on types of products, properties, materials, imaging technologies, and applications * Analyses of the global market trends with data from 2018-2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025 * Estimation of the current and potential market size for theranostics, and market share analysis on the basis of category, product type, application, and geographical region * Highlights of new technological developments related to theranostics, while outlining current technical issues * Review existing fields of application for theranostics and examination of emerging applications such as macular degeneration, gynecology, cutaneous hypersensitivity, and cardio-respiratory medicines * Identification of important technology and industry trends within each market segment with a holistic review of current industry players, including manufacturers of products used in theranostics, reagents, and instrumentation for theranostics research, as well as suppliers of theranostics-related services, technology developers, and future market participants * Assessment of latest technological developments and the most relevant global R&D activities related to theranostics, resulting in the issuance of patents * Analysis of the recently issued U.S. patents, with a summary of patents related to theranostic materials, processes, and applications * Comprehensive company profiles of the major market players, including Bayer, Bristol Myers Squibb, GE Healthcare, GlaxoSmithKline (GSK) and HitachiKey Topics Covered: Chapter 1 IntroductionChapter 2 Summary and Highlights Chapter 3 Market and Technology Background * Theranostics * The Diagnostic and Therapeutic Product Market * Milestones in the History of Theranostics and Recent Events * Current and Emerging Applications for Theranostics * Oncology * Cardiovascular Disorders * Respiratory, Inflammatory and Infectious Diseases * Neurological Disorders * Tissue Engineering * OthersChapter 4 Technology * Introduction * Strategies, Methods, Materials and Equipment for Theranostics * Diagnostic Functions * Therapeutic Functions * Theranostic Agents * Hydrogels * Microparticles * Latest Technological Developments, 2018 to Present * Oxygen Reactive Polymers for Traumatic Brain Injuries * Graphene Quantum Dots for Targeted Therapies * Theranostic Agent for Photoacoustic Imaging and Photothermal Therapy * Theranostic Agents for Metastatic Tumors * Other Relevant R&D ActivitiesChapter 5 Global Markets * Analysis Outline * Global Market Summary * Current Market Status * Market by Category * Market by Product Type * Market by Application * Market by Region * Market Growth Trends * Oncology * Cardiovascular Diseases * Respiratory, Inflammatory and Infectious Diseases * Neurological Disorders * Other Applications * Other Technological Trends * Regional Trends * Market Forecast * Market by Category * Market by Product Type * Market by Application * Market by RegionChapter 6 Global Industry Structure and Company Profiles * Leading Suppliers of Theranostic Technologies * Distribution of Leading Suppliers by Product Type and Region * Other Industry Players * Company Profiles * Astrid Pharma * Bayer * Bristol Myers Squibb * Canon Medical Systems * Caris Life Sciences * Carl Zeiss * Clarity Pharmaceuticals * Curium Pharma * Encapsula Nanosciences * Foundation Medicine * GE Healthcare * GlaxoSmithKline * Hitachi * Magforce * Merck KGaA * Perkinelmer * Pfizer * Roche * Siemens Healthcare * Thermo Fisher ScientificChapter 7 Patent Analysis * Introduction * Summary of Recently Awarded Patents * General Trends * Trends by Country and Region * Trends by Assignee * Trends by Patent Category * Trends by Material Type * Trends by ApplicationFor more information about this report visit https://www.researchandmarkets.com/r/814b6mResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
PetSmart, Inc. ("PetSmart") announced today that it together with its wholly-owned subsidiary, PetSmart Finance Corp. (the "Co-Issuer" and, together with PetSmart, the "Issuers"), intend to offer (the "Offering"), subject to market and other conditions, $1,200 million aggregate principal amount of senior first lien notes due 2027 (the "Secured Notes") and $1,150 million aggregate principal amount of senior notes due 2028 (the "Unsecured Notes" and, together with the Secured Notes, the "Notes") in a private offering. The Secured Notes will be senior secured obligations of the Issuers and will be guaranteed by certain of their wholly owned domestic subsidiaries. The Unsecured Notes will be senior unsecured obligations of the Issuers and will be guaranteed by certain of their wholly owned domestic subsidiaries.
The Montrose Port Authority has appointed two new board members, a new chairman and a new vice-chairman.
Pakistan's first metro line began operations Monday in the eastern city of Lahore following years of delays, in a country severely lacking public transport or modern infrastructure.
The victims were shot on Route 120, outside the entrance to the racetrack shortly after 9 p.m. Sunday night.
A call was made for more filmmakers in the Arab world to spotlight attention on the plight of child refugees and domestic violence at the fourth edition of the El Gouna Film Festival Sunday. “We need artists and filmmakers to spotlight violence against women and children,” said Noura Selim, executive director at the Sawiris Foundation […]